Recent research have the efficacy of RMP1-14, a recently created anti-mouse PD-1 antibody , for boosting malignant treatment. Unlike existing approaches, RMP1-14 exhibits increased affinity to murine PD-1, https://www.targetmol.com/compound/anti_mouse_pd_1_antibody_rmp1_14